Dr. Declan Walsh received the distinguished 2023 Walther Cancer Foundation Endowed Supportive Oncology Award at the annual American Society of Clinical Oncology (ASCO) meeting – Atrium Health
We’re incredibly proud to announce that Dr. Declan Walsh, Hemby Family Endowed Chair in supportive oncology at Atrium Health Levine Cancer Institute, received the distinguished 2023 Walther Cancer Foundation Endowed Supportive Oncology Award at the annual American Society of Clinical Oncology (ASCO) meeting.
This prestigious honor acknowledges those who have made invaluable contributions to palliative and supportive oncology care. Under Dr. Walsh’s leadership, patients at Atrium Health Levine Cancer Institute undergo comprehensive distress screening at diagnosis, ensuring early intervention and personalized care. This proactive approach has enhanced patient outcomes, demonstrating the significant benefits of integrated cancer care.
“Looking toward the future, our goal is to share the lessons we’ve learned and the model we’ve created with health care systems, both in the U.S. and globally,” said Walsh. “We want to see this type of comprehensive, supportive care become the standard for cancer treatment worldwide.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023